High-dose azathioprine has been independently associated with a moderate risk of both early and late non-Hodgkin lymphoma (NHL) in liver, heart and lung transplant patients. New research published in the British Journal of Haematology advocates avoiding high-dose azathioprine if possible, minimising dose and the careful surveillance of patient subgroups at high risk. “In this population-based ...
High-dose azathioprine linked to increased NHL risk for transplant patients
By Amanda Sheppeard
25 May 2016